Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
10%
Antisense Oligonucleotide
10%
Cell Viability
10%
Clinical Trial
80%
Cryoprotective Agent
40%
Cystic Fibrosis
40%
Cystic Fibrosis Transmembrane Conductance Regulator
40%
Diabetic Macular Edema
10%
Disease
10%
Drug Carrier
16%
Dry Eye
10%
Eye Disease
30%
Fibrosis
60%
Gene Delivery
40%
Glaucoma
56%
microRNA
40%
Myocardin
16%
Nanocarrier
5%
Nanoparticle
80%
Preclinical Study
10%
Receptor
5%
Retina Disease
10%
Serum Response Factor
6%
Side Effect
40%
Sirna 027
10%
Small Interfering RNA
100%
Solid Lipid Nanoparticle
85%
Therapeutic Effect
40%
Transcription Factors
16%
Keyphrases
Advanced Therapeutics
5%
Cargo
8%
Cryoprotectant
40%
DNA Delivery
40%
Entrapment Efficiency
8%
Exosomal Cargo
5%
Gene Therapy
8%
GFP Expression
8%
Healthy Condition
13%
Lipid Nanocarriers
8%
Lipid Nanoparticles
40%
Lipid Receptors
8%
Loss Function
8%
Messenger RNA (mRNA)
8%
Microinvasive Glaucoma Surgery
40%
Nanoparticles
32%
Nanoparticles Types
8%
Novel Lipids
8%
PEGylated Lipid Nanoparticles
40%
PH-sensitive Lipid
8%
Physicochemical Characteristics
8%
Profibrotic Genes
10%
QR-110
10%
Receptor Targets
8%
RNA Therapeutics
16%
Safety Self-efficacy
8%
Storage Conditions
40%
Storage Temperature
8%
Targeted Nanoparticles
8%
Therapy Strategy
13%
Transfection Efficiency
40%
Water-soluble Drug
5%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
40%
Cystic Fibrosis
40%
Cystic Fibrosis Transmembrane Conductance Regulator
40%
Gene Therapy
26%
Genetics
26%
Genome Editing
13%
Genome Editing
13%
Immune Response
13%
Locus Control Region
26%
Medical Genetics
40%
Messenger RNA
26%
RNA
40%
Surface Property
13%
Tissue Specificity
13%
